Randomized, Double-blind, Placebo and Comparator-controlled, Parallel-group, Multi-center Trial Assessing the Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy
Phase of Trial: Phase III
Latest Information Update: 03 Feb 2017
At a glance
- Drugs Pitolisant (Primary) ; Modafinil
- Indications Narcolepsy
- Focus Therapeutic Use
- Acronyms Harmony-I-bis
- Sponsors Bioprojet
- 22 Sep 2012 Planned number of patients changed from 180 to 185.
- 18 Jul 2012 New trial record
- 01 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.